Literature DB >> 7588089

Skin cancer. Recognition and treatment.

R Marks1, R J Motley.   

Abstract

There is a worldwide increasing incidence of all forms of skin cancer among Whites as a result of increased sun exposure. Basal cell and squamous cell carcinomas, the most common tumours of the head and neck, are relatively benign neoplasms of elderly individuals. Malignant melanoma, however, has the potential for early metastasis and may occur in early adult life. The increase in malignant melanoma is particularly disturbing, and is a clear indication for skin screening clinics. Although surgical excision is the primary treatment of choice for skin tumours, various drugs may be of therapeutic value. Fluorouracil cream is a useful treatment for solar keratoses. Retinoids are particularly suitable for patients with large numbers of nonmelanoma skin cancer lesions and solar keratoses. For malignant melanoma, arterial limb perfusion with high concentrations of cytotoxic drugs may be performed both as an adjunctive and therapeutic manoeuvre. Treatment of metastatic melanoma with cytotoxic agents is associated with low response rates and high toxicity. However, trials with combined interferon-alpha, interleukin-2 and cytostatic drugs have produced promising preliminary results.

Entities:  

Mesh:

Year:  1995        PMID: 7588089     DOI: 10.2165/00003495-199550010-00005

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  41 in total

1.  Should the excisional biopsy of clinically probable melanomas include a margin that might also serve as adequate for treatment?

Authors:  P A Ledwig; J K Robinson
Journal:  Arch Dermatol       Date:  1990-07

2.  Reasons for poor prognosis in British patients with cutaneous malignant melanoma.

Authors:  V R Doherty; R M MacKie
Journal:  Br Med J (Clin Res Ed)       Date:  1986-04-12

3.  Skin cancer in immunosuppressed patients.

Authors:  J C Maize
Journal:  JAMA       Date:  1977-04-25       Impact factor: 56.272

4.  Multiple self-healing squamous epithelioma.

Authors:  M A Ferguson-Smith; D C Wallace; Z H James; J H Renwick
Journal:  Birth Defects Orig Artic Ser       Date:  1971-06

5.  Metastases in dermatological patients with squamous cell carcinoma.

Authors:  R Møller; F Reymann; K Hou-Jensen
Journal:  Arch Dermatol       Date:  1979-06

6.  Risk factors for developing cutaneous melanoma and criteria for identifying persons at risk: multicenter case-control study of the Central Malignant Melanoma Registry of the German Dermatological Society.

Authors:  C Garbe; P Büttner; J Weiss; H P Soyer; U Stocker; S Krüger; M Roser; J Weckbecker; R Panizzon; F Bahmer
Journal:  J Invest Dermatol       Date:  1994-05       Impact factor: 8.551

Review 7.  Chemotherapy and chemoimmunotherapy in disseminated malignant melanoma.

Authors:  C Garbe
Journal:  Melanoma Res       Date:  1993-08       Impact factor: 3.599

8.  The ABCD rule of dermatoscopy. High prospective value in the diagnosis of doubtful melanocytic skin lesions.

Authors:  F Nachbar; W Stolz; T Merkle; A B Cognetta; T Vogt; M Landthaler; P Bilek; O Braun-Falco; G Plewig
Journal:  J Am Acad Dermatol       Date:  1994-04       Impact factor: 11.527

Review 9.  Targeted therapy for malignant melanoma.

Authors:  I R Hart; R G Vile
Journal:  Curr Opin Oncol       Date:  1994-03       Impact factor: 3.645

10.  Spreading pigmented actinic keratosis. An electron microscopic study.

Authors:  S M Dinehart; R L Sanchez
Journal:  Arch Dermatol       Date:  1988-05
View more
  3 in total

Review 1.  5-Methoxypsoralen. A review of its effects in psoriasis and vitiligo.

Authors:  W McNeely; K L Goa
Journal:  Drugs       Date:  1998-10       Impact factor: 9.546

Review 2.  Diclofenac/hyaluronic acid.

Authors:  D C Peters; R H Foster
Journal:  Drugs Aging       Date:  1999-04       Impact factor: 3.923

3.  Treatment of advanced, recurrent, resistant to previous treatments basal and squamous cell skin carcinomas with a synergistic formulation of interferons. Open, prospective study.

Authors:  Lorenzo Anasagasti-Angulo; Yanelda Garcia-Vega; Silvia Barcelona-Perez; Pedro Lopez-Saura; Iraldo Bello-Rivero
Journal:  BMC Cancer       Date:  2009-07-30       Impact factor: 4.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.